Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Novartis' brain delivery platform option deal worth up to $175M; Neumora's next steps
1 hour ago
News Briefing
Who pays the most in biopharma? We analyzed median pay at 177 companies
2 hours ago
Pharma
Trump’s CDC nominee Monarez advances to full Senate
2 hours ago
Pharma
Rhythm says oral rare obesity drug clears Phase 2 test, plans tweaks to formulation
4 hours ago
R&D
Revolution and Iambic to combine data and AI models in R&D deal for cancer drugs
4 hours ago
Deals
AI
AstraZeneca’s Alexion inks AAV capsid deal with JCR Pharma
5 hours ago
R&D
Cell/Gene Tx
Updated: Merck drops $10B for respiratory drugmaker Verona Pharma in its first acquisition of 2025
5 hours ago
Deals
Pharma
FDA approves new dosing of Lilly’s Alzheimer’s drug to lower brain swelling risks
5 hours ago
Pharma
Nimble radiopharma biotech Actithera gets $75M to enter the clinic
9 hours ago
Financing
Startups
Supreme Court halts California order that blocked RFK Jr. from reorganizing HHS
19 hours ago
Law
'CRISPR Cures' center launches with $20M to make customized gene editing therapies
20 hours ago
R&D
Cell/Gene Tx
Oura’s healthcare bet
20 hours ago
Health Tech
Trump hints at tariff grace period for pharma companies to bring manufacturing to US
20 hours ago
Pharma
Manufacturing
Otsuka’s Taiho reports Phase 3 fail for Duchenne muscular dystrophy drug
21 hours ago
Pharma
In first half of 2025, novel drug approvals are in line with previous years
21 hours ago
Pharma
FDA+
Recursion takes full rights to rare genetic disorder drug; CStone out-licenses cancer drug in Europe
Yesterday
News Briefing
Biopharma's 20 highest-paid CEOs of 2024 with $20M+ paydays
Yesterday
People
Pharma
ProKidney's stock shoots higher after mixed Phase 2 data
Yesterday
R&D
Quanterix closes Akoya deal after competing bid
Yesterday
Deals
Diagnostics
Exclusive: Startup raises $45M for universal flu vaccines made with mRNA
Yesterday
Startups
R&D
Shell company Concentra has found its rhythm, with Cargo Therapeutics as its latest buyout target
Yesterday
Deals
Cell/Gene Tx
Singaporean biotech gets China thumbs-up for study of potentially curative HBV cell therapy
Yesterday
R&D
China
Novartis maps launch of malaria drug for newborns after Swiss approval
Yesterday
Pharma
Clinician groups sue RFK Jr. and HHS over Covid-19 vaccine recommendation changes
Yesterday
R&D
Pharma
1
2
3
4
Next page
Last page
